MSAC Consultation Survey - Application 1786 - resubmission

Overview

A further period of consultation is open on application 1786 – FreeStyle Libre 2 continuous glucose monitoring (CGM) System for people with insulin-dependent type 2 diabetes, gestational diabetes and type 3c diabetes, for consideration by the Medical Services Advisory Committee (MSAC) and its Evaluation Subcommittee (ESC). Consultation input helps MSAC and its subcommittees to better understand how a proposed health service or technology fits in the Australian health care environment.

MSAC previously considered application 1786 – FreeStyle Libre 2 continuous glucose monitoring system at its meeting on 31 July 2025. The application requested National Diabetes Services Scheme (NDSS) funding of the FreeStyle Libre 2 (later amended to also include the FreeStyle Libre 2+) continuous glucose monitoring system for:

• people with type 2 diabetes (T2D) requiring treatment with insulin
• pregnant women with gestational diabetes
• people with type 3c diabetes requiring insulin. This group of people was subsequently expanded to include all people aged ≥21 years with other conditions similar to type 1 diabetes requiring insulin.

After considering the strength of the available evidence in relation to comparative safety, clinical effectiveness, cost-effectiveness and total cost, MSAC deferred its decision on public funding for this application, as it required more information. MSAC advised that a revised resubmission should focus on the subpopulations who have a greater clinical need for CGM and are more likely to benefit from CGM, as well as presenting evidence around two different patterns of usage, and any more recent clinical evidence of effectiveness.  MSAC further advised that a resubmission should present a revised economic evaluation focussed on the populations with a higher clinical need and addressing the issues in the model. MSAC considered revised estimates of utilisation would be required to more accurately estimate the size of the subpopulations.

The Public Summary Document (PSD) for application 1786 sets out MSAC’s reasoning and concerns. You can view the PSD as a PDF document (right click on the link and select 'open link in new tab'). If you would prefer to view as a word document, go to the application webpage and scroll to the 'Application Documents' section, locate the PSD and select 'Download Word'. This will download the PSD to your device.  

How to provide input

This survey asks questions directly related to issues raised by MSAC in the PSD. You can give input to MSAC on these questions by completing the online survey. To help your preparation, you can download a copy of the questions asked in the survey. To do this, click on the 'Survey Questions' link below (under 'Related'). If you have trouble using the online survey, you can complete this Microsoft Word version and email to commentsMSAC@health.gov.au.

If you have previously provided consultation input on MSAC application 1786 – FreeStyle Libre 2 continuous glucose monitoring (CGM) System, ESC and MSAC will review this input again when they next consider this application. There is no need to give further input unless you want to comment on the specific questions in this survey.